Patient Education Sheet Library
Search Results
Downloads
Download (English) – 0.62MBPembrolizumab and Ipilimumab
The combination of pembrolizumab and ipilimumab is used for skin cancer.
Treatment Given by InfusionDownloads
Pembrolizumab, Trastuzumab and FOLFOX
Pembrolizumab, trastuzumab, and FOLFOX is used for stomach cancer and esophageal cancer.
Treatment Given by InfusionDownloads
Pembrolizumab, Gemcitabine, and Cisplatin
The combination of pembrolizumab, gemcitabine, and cisplatin is used for biliary tract cancer.
Treatment Given by InfusionDownloads
Pembrolizumab, Fluorouracil, and Cisplatin
The combination of pembrolizumab, fluorouracil (5-FU), and cisplatin is used for stomach and esophagus cancers.
Treatment Given by InfusionDownloads
Pembrolizumab, Capecitabine, and Cisplatin
The combination of pembrolizumab, capecitabine, and cisplatin is used for stomach and esophagus cancers.
Treatment Given by Infusion Treatment Taken by MouthDownloads
Pembrolizumab and Albumin-Bound Paclitaxel
Pembrolizumab and Albumin-bound Paclitaxel egimen is used to treat breast cancer.
Treatment Given by InfusionDownloads
Axitinib and Pembrolizumab
The combination of axitinib and pembrolizumab is used for kidney cancer.
Treatment Given by Infusion Treatment Taken by MouthDownloads
Lenvatinib and Pembrolizumab
The combination of lenvatinib and pembrolizumab is used for kidney cancer and endometrial cancer.
Treatment Given by Infusion Treatment Taken by MouthDownloads
Enfortumab Vedotin and Pembrolizumab
The combination of enfortumab vedotin and pembrolizumab is used for bladder cancer and cancers of…
Treatment Given by InfusionDownloads
Popular Searches
PES Review Committee
The Patient Education Sheet (PES) Committee is a multidisciplinary team of oncology professionals who guide the development and review of these important resources. This committee ensures that every PES is accurate, clear, and meaningful for patients and caregivers navigating cancer treatment.
Led by NCODA and supported through collaboration with three leading professional organizations—ACCC, HOPA, and ONS—the committee combines expertise from across the oncology care spectrum. Together, they uphold best practices, promote consistency in patient education, and remain committed to improving outcomes through accessible, patient-centered information.
